Lisa E. Davis
Impact in
- Epidemiology top 1%
- Autophagy in Disease and Therapy
- Genetics top 10%
- Glioma Diagnosis and Treatment
Papers in
-
- Multiple Myeloma Research and Treatments 6
- Oncology 8
- Cancer Treatment and Pharmacology 3
- Co-authors
- Ravi K. Amaravadi (8 shared papers)Shengfu Piao (4 shared papers)Laura Pontiggia (3 shared papers)Daniel F. Heitjan (3 shared papers)Yunyoung Claire Chang (3 shared papers)Quentin W. Mcafee (2 shared papers)Peter James O'Dwyer (4 shared papers)Edward C. Li (1 shared paper)
- Journals
- Blood (5 papers)Autophagy (5 papers)American Journal of Health-System Pharmacy (2 papers)Cancer Nursing (2 papers)Clinical Cancer Research (2 papers)
- Partner nations
- United StatesPuerto Rico
In The Last Decade
Lisa E. Davis
35 papers receiving 2.8k citations
Lisa E. Davis's Hit Papers
Peers
Comparison fields: 5 of 88
- Epidemiology 1.6k
- Genetics 108
- Oncology 255
- Cancer Research 137
- Hematology 99
Countries citing papers authored by Lisa E. Davis
This map shows the geographic impact of Lisa E. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa E. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa E. Davis more than expected).
Fields of papers citing papers by Lisa E. Davis
This network shows the impact of papers produced by Lisa E. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa E. Davis. The network helps show where Lisa E. Davis may publish in the future.
Co-authors
The 25 scholars most cited alongside Lisa E. Davis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme Hit paper breakdown → | 2014 | 452 |
| 2 | Combined MTOR and autophagy inhibition Hit paper breakdown → | 2014 | 373 |
| 3 | 2012 | 368 | |
| 4 | 2014 | 336 | |
| 5 | 2014 | 323 | |
| 6 | 2014 | 263 | |
| 7 | 2019 | 127 | |
| 8 | 2003 | 99 | |
| 9 | 2005 | 86 | |
| 10 | 2020 | 58 | |
| 11 | 2005 | 43 | |
| 12 | 2019 | 38 | |
| 13 | 1994 | 37 | |
| 14 | 2018 | 30 | |
| 15 | 1993 | 29 | |
| 16 | 2009 | 26 | |
| 17 | 1997 | 25 | |
| 18 | 2019 | 25 | |
| 19 | 1994 | 22 | |
| 20 | 1994 | 22 |
About Lisa E. Davis
Lisa E. Davis is a scholar working on Hematology, Oncology, Pharmacology, Genetics and Pediatrics, Perinatology and Child Health, having authored 37 papers that have together received 2.9k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (6 papers), Autophagy in Disease and Therapy (4 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Advanced Breast Cancer Therapies (3 papers), Cancer Treatment and Pharmacology (3 papers), Pharmaceutical studies and practices (3 papers), Pharmacy and Medical Practices (3 papers) and Inflammatory mediators and NSAID effects (2 papers). The work is most often cited by research in Epidemiology (1.6k citations), Genetics (108 citations), Oncology (255 citations), Cancer Research (137 citations) and Hematology (99 citations). Lisa E. Davis has collaborated with scholars based in United States and Puerto Rico. Frequent co-authors include Ravi K. Amaravadi, Shengfu Piao, Laura Pontiggia, Daniel F. Heitjan, Yunyoung Claire Chang, Quentin W. Mcafee, Peter James O'Dwyer, Edward C. Li, Andrea B. Troxel and Reshma A. Rangwala. Their work appears in journals such as Blood, Autophagy, American Journal of Health-System Pharmacy, Cancer Nursing and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.